Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Consent Decree’s Impact Is Limited, GSK Says

28 Apr 2005

• By Lee Kalowski

Related Content

GSK Expects Paxil CR, Avandamet Shipments To Resume “Within Months”

28 Apr 2005

FDA Seizure Of Paxil CR, Avandamet Follows GSK's Failure To Recall All Lots

04 Mar 2005

Schering-Plough's Asmanex Clears FDA For Asthma

31 Mar 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.